Abstract:Bruno Bordoni, 1 Allan Escher, 2 Elena Compalati, 1 Luca Mapelli, 1 Anastasia Toccafondi 1 1 Department of Cardiology, Institute of Hospitalization and Care with Scientific Address, Foundation Don Carlo Gnocchi IRCCS S Maria Nascente, Milano, Italy; 2 Anesthesiology/Pain Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Correspondence: Bruno Bordoni, Email Chronic obstructive pulmonary disease (COPD) is a constant and chronic narrowing of the respiratory airways, with numerous associated symptoms, not always related to the pathological adaptation of the lungs. Statistical projections show that COPD could become the third leading cause of death globally by 2030, with a significant increase in deaths by 2060. Skeletal muscle dysfunction, including the diaphragm, is one of the causes linked to the increase in mortality and hospitalization. Little emphasis is given by the scientific literature to the importance of the diaphragm towards functional neuromotor pathological expressions. The article reviews the adaptation of the skeletal muscles, with greater attention to the adaptations of the diaphragm, thereby highlighting the non-physiological variations that the main respiratory muscle undergoes and the neuromotor impairment found in COPD. The text could be an important reflection from a clinical and rehabilitation point of view, to direct greater attention to the function and adaptation of the diaphragm muscle. Keywords: diaphragm, COPD, physiotherapy, rehabilitation, pain, fascia, ageing, osteopathic Chronic obstructive pulmonary disease (COPD) is a complex and constantly evolving pathology, which is characterized by a progressive and constant limitation of the available air volume (airflow obstruction). 1 COPD could become the third leading cause of death for the population by 2030. 1 The Global Initiative for Chronic Obstructive Lung Disease (GOLD) identifies COPD as: a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. 2 GOLD estimates that the number of patients who will die of COPD in 2060 will be approximately 5.4 million deaths annually, compared to 3.2 million deaths in 2015 annually. 3 In the USA, the incidence of the disease involves 10.2–20.9% of the population, in Europe, despite a trend of reduction in mortality and a decreased difference between men and women, the percentage of findings remains high (3–26.1%). 3 Some data from Africa, few and not covering all geographical areas, show COPD detection rates of 1.6–23.8%; in Latin America, the percentage is between 30% and 31.1%. 3 In China, the percentage is about 8.6% (data from 2018), and highly variable and incomplete values for other Asian regions, with an average of 3.5–6.7%. 3 COPD is considered as the fifth cause of burden on the economy of the various states due to recurring hospitalizations and pharmacological treatments. 4 Probably, this global economic aggravation derives from the fact that this pathology does not involve only the pulmonary area but develops many dysfunctions and physiological alterations involving the whole-body system. 4 Although emphysema and chronic bronchitis are responsible for triggering the chronicity of the disease, the patient does not always go to hospital for respiratory reasons, but for important cardiac problems, fractures, the onset of lung tumours, mood disorders, muscle complex that prevent independence and severe metabolic alterations. 1,5 Furthermore, it is not always possible to correctly assess the severity of COPD, as there is only a moderate relationship between pulmonary adaptation and the reduction in the patient's quality of life. 6 COPD is a systemic disease, and as such it is expressed with multiple symptoms, such as insomnia and drowsiness, dry mouth, anorexia, pain (local or from multiple involved areas), nausea, constipation, gastric reflux, dysphagia, sleep apnea, cough, fatigue and shortness of breath, wheezing and dyspnea, temporomandibular disorders and urinary incontinence. 2,5,7–10 Some symptoms related to the presence of COPD and which have a negative impact on the mortality and morbidity of patients, are the finding of anxiety and depression, with values ranging from 8% up to a maximum of 80% of patients. 1,5,11 Functional and structural alterations of the skeletal muscles (almost all patients), lack of coordination and an increase in accidental falls cause a decrease in active movement, leading to a decline in quality of life, an increase in mortality and in -Abstract Truncated-

Inspiratory muscle dysfunction mediates and predicts a disease continuum of hypercapnic failure in chronic obstructive pulmonary disease

Respiratory muscle function and activation in chronic obstructive pulmonary disease

Hypercapnia and lung function parameters in chronic obstructive pulmonary disease

Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation

Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function

Absence of Dynamic Hyperinflation During Exhaustive Exercise in Severe COPD Reflects Submaximal IC Maneuvers Rather Than a Nonhyperinflator Phenotype

Respiratory Mechanics and Diaphragmatic Dysfunction in COPD Patients Who Failed Non-Invasive Mechanical Ventilation

[Causes of CO2 retention in patients with chronic obstructive lung disease]

Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction

Haemodynamic compensations for exercise tissue oxygenation in early stages of COPD: an integrated cardiorespiratory assessment study

Differences of ventilatory muscle recruitment and work of breathing in COPD and interstitial lung disease during exercise: a comprehensive evaluation

The Importance of the Diaphragm in Neuromotor Function in the Patient with Chronic Obstructive Pulmonary Disease

Diaphragmatic surface EMG and COPD Inflammatory profile

Inspiratory Capacity Manoeuvres May Underestimate Dynamic Hyperinflation in Patients with COPD; the Explanation for Apparent Non-Inflators

Beyond Spirometry: Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPD

A Study of Respiratory Muscle Strength in Patients with Chronic Obstructive Pulmonary Disease

Reversibility of Hypercapnia after an Acute Exacerbation of COPD

Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD

Respiratory muscle strength can improve the prognostic assessment in COPD

Effective non-invasive ventilation reduces muscle sympathetic nerve activity in patients with stable hypercapnic COPD